Cipla Limited (CIPLA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.041x

Based on the latest financial reports, Cipla Limited (CIPLA) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs13.45 Billion ≈ $145.49 Million USD) by net assets (Rs330.25 Billion ≈ $3.57 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CIPLA market cap overview for the company's overall valuation and market capitalisation.

Cipla Limited - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Cipla Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cipla Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cipla Limited ranked by their cash flow conversion efficiency. Explore cash flow quality index of Cipla Limited to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Revvity Inc.
NYSE:RVTY
0.016x
Sonova H Ag
SW:SOON
0.169x
CARLSBERG B DK20 ADR 1/5
F:CBGC
N/A
Sociedad Quimica y Minera de Chile SA ADR B
NYSE:SQM
0.078x
NIPPON YUSEN K.K.SP.DR1/5
F:NYK
N/A
Hong Leong Bank Bhd
KLSE:5819
0.055x
Exelixis Inc
NASDAQ:EXEL
0.154x
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
0.061x

Annual Cash Flow Conversion Efficiency for Cipla Limited (2004–2025)

The table below shows the annual cash flow conversion efficiency of Cipla Limited from 2004 to 2025. View Cipla Limited share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs312.89 Billion
≈ $3.38 Billion
Rs50.05 Billion
≈ $541.27 Million
0.160x +3.71%
2024-03-31 Rs268.03 Billion
≈ $2.90 Billion
Rs41.34 Billion
≈ $447.07 Million
0.154x +12.97%
2023-03-31 Rs237.14 Billion
≈ $2.56 Billion
Rs32.38 Billion
≈ $350.14 Million
0.137x -13.31%
2022-03-31 Rs211.17 Billion
≈ $2.28 Billion
Rs33.26 Billion
≈ $359.68 Million
0.157x -22.05%
2021-03-31 Rs185.86 Billion
≈ $2.01 Billion
Rs37.55 Billion
≈ $406.11 Million
0.202x +5.73%
2020-03-31 Rs160.57 Billion
≈ $1.74 Billion
Rs30.68 Billion
≈ $331.84 Million
0.191x +73.39%
2019-03-31 Rs153.44 Billion
≈ $1.66 Billion
Rs16.91 Billion
≈ $182.89 Million
0.110x +9.87%
2018-03-31 Rs145.82 Billion
≈ $1.58 Billion
Rs14.63 Billion
≈ $158.19 Million
0.100x -45.32%
2017-03-31 Rs129.82 Billion
≈ $1.40 Billion
Rs23.82 Billion
≈ $257.58 Million
0.183x +25.06%
2016-03-31 Rs118.66 Billion
≈ $1.28 Billion
Rs17.41 Billion
≈ $188.26 Million
0.147x +37.30%
2015-03-31 Rs109.82 Billion
≈ $1.19 Billion
Rs11.73 Billion
≈ $126.90 Million
0.107x -40.73%
2014-03-31 Rs86.68 Billion
≈ $937.38 Million
Rs15.63 Billion
≈ $169.00 Million
0.180x +16.34%
2013-03-31 Rs90.19 Billion
≈ $975.34 Million
Rs13.98 Billion
≈ $151.15 Million
0.155x -30.88%
2012-03-31 Rs76.38 Billion
≈ $826.07 Million
Rs17.13 Billion
≈ $185.23 Million
0.224x +45.08%
2011-03-31 Rs66.33 Billion
≈ $717.29 Million
Rs10.25 Billion
≈ $110.86 Million
0.155x -12.42%
2010-03-31 Rs59.11 Billion
≈ $639.21 Million
Rs10.43 Billion
≈ $112.80 Million
0.176x +104.69%
2009-03-31 Rs43.48 Billion
≈ $470.20 Million
Rs3.75 Billion
≈ $40.54 Million
0.086x -11.79%
2008-03-31 Rs37.55 Billion
≈ $406.11 Million
Rs3.67 Billion
≈ $39.69 Million
0.098x -5.42%
2007-03-31 Rs32.36 Billion
≈ $349.99 Million
Rs3.34 Billion
≈ $36.17 Million
0.103x -26.06%
2006-03-31 Rs19.83 Billion
≈ $214.48 Million
Rs2.77 Billion
≈ $29.97 Million
0.140x +8.56%
2005-03-31 Rs15.54 Billion
≈ $168.02 Million
Rs2.00 Billion
≈ $21.63 Million
0.129x -35.24%
2004-03-31 Rs12.64 Billion
≈ $136.70 Million
Rs2.51 Billion
≈ $27.17 Million
0.199x --

About Cipla Limited

NSE:CIPLA India Drug Manufacturers - Specialty & Generic
Market Cap
$12.19 Billion
Rs1.13 Trillion INR
Market Cap Rank
#1928 Global
#72 in India
Share Price
Rs1395.00
Change (1 day)
+0.72%
52-Week Range
Rs1192.40 - Rs1663.60
All Time High
Rs1683.00
About

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, suc… Read more